Topic: P53

The discussion shifts to the discovery of 15 biological laboratories in Ukraine funded by the U.S. Department of Defense. Dr. Richard Fleming argues that these facilities continued gain-of-function research despite official bans. He also explains how the spike protein may interfere with the p53 enzyme system, which normally protects the body from developing cancer, effectively lowering human biological defenses.

Pathologist Dr. Ryan Cole discusses an observed uptick in aggressive cancers and the reactivation of stable cancers post-vaccination. He explains the biological mechanism involving the p53 "guardian of the genome" and how the spike protein may interfere with tumor suppressor genes. The segment calls for federal funding to investigate these oncological signals.

Shroyer and the hearing panelists discuss the mechanisms by which the spike protein may interfere with the P53 gene, known as the "guardian of the genome." They argue that the mRNA technology was never properly tested for its cancer-causing potential. Shroyer criticizes the Pfizer CEO for pushing annual "jabs" despite these emerging safety concerns.

Recent studies suggest the vaccine spike protein may interact with cancer-producing genes like BRCA and P53. The FDA has issued warnings regarding myocarditis and Guillain-Barré syndrome following vaccination. Dr. Peter McCullough also addresses reports of severe menstrual abnormalities and uterine bleeding in women, attributing them to the distribution of spike proteins to reproductive tissues.